Michel J. W. Zaal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michel J. W. Zaal has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
H. J. Völker‐Dieben
VU University Medical Centre, Amsterdam, The Netherlands
1 shared publicationHennie J. Völker-Dieben
Department of Ophthalmology, VU Medical Center, Amsterdam, The Netherlands
1 shared publicationJ. D'Amaro
VU University Medical Centre, Amsterdam, The Netherlands
1 shared publicationJoe D'AMaro
Department of Ophthalmology, VU Medical Center, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 29 May 2003
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 81 (3) , 216-220
Visual prognosis in immunocompetent patients with herpes zoster ophthalmicus
: Purpose: To determine the normal spectrum of ocular complications and associated visual outcome in patients with herpes zoster ophthalmicus.Methods: This prospective observational cohort study included 73 immunocompetent adults with herpes zoster ophthalmicus, referred by their general practitioners within 7 days of skin rash onset. The follow‐up period was 6 months. All patients received a 7–14‐day course of systemic aciclovir treatment combined with longterm application of a lubricating ophthalmic ointment as long as the corneal epithelium was affected. Topical corticosteroids were strictly avoided in the acute phase of ocular disease. Acquired visual loss scores at 1, 2 and 6 months were based on best corrected visual acuity (BCVA) level and evaluation of the ophthalmological history and findings.Results: Ophthalmic herpes zoster led to a variety of transient inflammatory reactions within the anterior eye segment of the involved side in 46 patients (63%), but did not seriously compromise their ultimate visual outcome. Mild to moderate visual loss, with corrected VA between 0.3 and 0.8, was found in 17 patients at 1 month (23%), in 10 patients at 2 months (14%) and in seven patients at 6 months follow‐up (10%). None of the patients developed visual loss with a corrected VA of less than 0.3.Conclusion: Functional vision was retained in all ophthalmic zoster patients referred to the ophthalmologist in the acute phase of the disease by vigorous antiviral treatment and adequate prevention of corneal exposure.
- 29 May 2003
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 81 (3) , 216-220
Open AccessVisual prognosis in immunocompetent patients with herpes zoster ophthalmicus
: Purpose: To determine the normal spectrum of ocular complications and associated visual outcome in patients with herpes zoster ophthalmicus.Methods: This prospective observational cohort study included 73 immunocompetent adults with herpes zoster ophthalmicus, referred by their general practitioners within 7 days of skin rash onset. The follow‐up period was 6 months. All patients received a 7–14‐day course of systemic aciclovir treatment combined with longterm application of a lubricating ophthalmic ointment as long as the corneal epithelium was affected. Topical corticosteroids were strictly avoided in the acute phase of ocular disease. Acquired visual loss scores at 1, 2 and 6 months were based on best corrected visual acuity (BCVA) level and evaluation of the ophthalmological history and findings.Results: Ophthalmic herpes zoster led to a variety of transient inflammatory reactions within the anterior eye segment of the involved side in 46 patients (63%), but did not seriously compromise their ultimate visual outcome. Mild to moderate visual loss, with corrected VA between 0.3 and 0.8, was found in 17 patients at 1 month (23%), in 10 patients at 2 months (14%) and in seven patients at 6 months follow‐up (10%). None of the patients developed visual loss with a corrected VA of less than 0.3.Conclusion: Functional vision was retained in all ophthalmic zoster patients referred to the ophthalmologist in the acute phase of the disease by vigorous antiviral treatment and adequate prevention of corneal exposure.
- 11 February 2003
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 241 (3) , 187-191
Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus
Purpose To determine the prognostic value of nasociliary skin lesions (Hutchinson's sign) for ocular inflammation and corneal sensory denervation in acute herpes zoster ophthalmicus. Methods A longitudinal observational study with a 2-month follow-up was performed involving 83 non-immunocompromised adults with acute herpes zoster ophthalmicus, with a skin rash duration of less than 7 days, referred by their general practitioner. All skin lesions at the tip, the side and the root of the nose, representing the dermatomes of the external nasal and infratrochlear branches of the nasociliary nerve, were documented by taking photographs and marking anatomical drawings. Ocular inflammatory signs were observed by slit-lamp biomicroscopy, and corneal sensitivity was measured with the Cochet–Bonnet esthesiometer at 2-month follow-up. Results Hutchinson's sign was a powerful predictor of ocular inflammation and corneal denervation in herpes zoster ophthalmicus [relative risks: 3.35 (CI 95%: 1.82–6.15) and 4.02 (CI 95%:1.55–10.42), respectively]. The manifestation of herpes zoster skin lesions at the dermatomes of both nasociliary branches was invariably associated with the development of ocular inflammation. Conclusion Clinicians should be alert for early skin lesions within the complete nasociliary dermatome, because they are a reliable prognostic sign of sight-threatening ocular complications in acute herpes zoster ophthalmicus.
- 11 February 2003
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 241 (3) , 187-191
Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus
Purpose To determine the prognostic value of nasociliary skin lesions (Hutchinson's sign) for ocular inflammation and corneal sensory denervation in acute herpes zoster ophthalmicus. Methods A longitudinal observational study with a 2-month follow-up was performed involving 83 non-immunocompromised adults with acute herpes zoster ophthalmicus, with a skin rash duration of less than 7 days, referred by their general practitioner. All skin lesions at the tip, the side and the root of the nose, representing the dermatomes of the external nasal and infratrochlear branches of the nasociliary nerve, were documented by taking photographs and marking anatomical drawings. Ocular inflammatory signs were observed by slit-lamp biomicroscopy, and corneal sensitivity was measured with the Cochet–Bonnet esthesiometer at 2-month follow-up. Results Hutchinson's sign was a powerful predictor of ocular inflammation and corneal denervation in herpes zoster ophthalmicus [relative risks: 3.35 (CI 95%: 1.82–6.15) and 4.02 (CI 95%:1.55–10.42), respectively]. The manifestation of herpes zoster skin lesions at the dermatomes of both nasociliary branches was invariably associated with the development of ocular inflammation. Conclusion Clinicians should be alert for early skin lesions within the complete nasociliary dermatome, because they are a reliable prognostic sign of sight-threatening ocular complications in acute herpes zoster ophthalmicus.